medigraphic.com
Instituto Nacional de Salud Pública

2016, Número 4

<< Anterior Siguiente >>

salud publica mex 2016; 58 (4)


Contribución individual e importancia relativa del auto-cuidado y la calidad de la atención en el control glucémico de la diabetes tipo 2

Martínez YV, Campbell SM, Hann M, Bower P

Idioma: Ingles.
Referencias bibliográficas: 42
Paginas: 404-411
Archivo PDF: 243.02 Kb.


RESUMEN

Objetivo. Evaluar la importancia relativa del autocuidado (AU) y calidad de la atención (CA) para predecir control glucémico en diabetes mellitus tipo 2 (DM2). Material y métodos. Estudio longitudinal en 204 adultos con DM2. AU y CA evaluados en la medición basal. HbA1c evaluada en la medición basal y a los seis meses. Resultados. A los seis meses, ninguna de las mediciones de AU se asoció significativamente con HbA1c. La intensificación en el tratamiento (IT) (proxy de CA) se asoció con disminución de HbA1c. Otras variables asociadas con HbA1c: HbA1c en medición basal, edad, duración de diabetes, y combinación de anti-hiperglucemiantes. En un análisis exploratorio, los participantes que no recibieron IT pero desempeñaron más conductas de AU tuvieron niveles más bajos de HbA1c. Conclusión.IT parece ser más importante para el control glucémico que AU, pero la interacción entre IT y conductas de AU se deben estudiar con más profundidad


REFERENCIAS (EN ESTE ARTÍCULO)

  1. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352(9131):854- 865. http://doi.org/ctn95c

  2. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837-853. http://doi.org/b2r32r

  3. American Diabetes Association. (6) Glycemic targets. Diabetes Care 2015;38 Suppl:S33-S40. http://doi.org/bfdb

  4. Diagnostico y tratamiento de la diabetes mellitus tipo 2. Mexico: Instituto Mexicano del Seguro Social, 2009.

  5. National Collaborating Centre for Chronic Conditions. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). London: Royal College of Physicians, 2008.

  6. Diagnostico, metas de control ambulatorio y referencia oportuna de prediabetes y diabetes mellitus tipo 2 en el primer nivel de atencion. Mexico: Secretaría de Salud, 2013.

  7. Si D, Bailie R, Weeramanthri T. Effectiveness of chronic care modeloriented interventions to improve quality of diabetes care: a systematic review. Prim Health Care Res Dev 2008;9:25-40. http://doi.org/d4pqbk

  8. Parchman ML, Pugh JA, Noel PH, Larme AC. Continuity of care, self-management behaviors, and glucose control in patients with type 2 diabetes. Med Care 2002;40(2):137-144. http://doi.org/bgrhrh

  9. Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, et al. Why don‘t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med 2008;23(5):588-594. http://doi.org/d3j6kw

  10. O’Connor PJ, Asche SE, Crain AL, Rush WA, Whitebird RR, Solberg LI, Sperl-Hillen JM. Is patient readiness to change a predictor of improved glycemic control? Diabetes Care 2004;27(10):2325-2329. http://doi.org/b6h8fc

  11. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002;288(15):1909-1914. http://doi.org/dq3phx

  12. Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev 2001;(1):CD001481.

  13. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001;24(3):561-587. http://doi.org/cstvqw

  14. Martinez Y, Campbell SM, Hann M, Bower P. The relationship between quality of care and self-management in patients with type 2 diabetes: a cross-sectional survey in primary care in Mexico. Qual Prim Care. Quality in Primary Care 2014;22(6):262-269.

  15. Garcia AA, Villagomez ET, Brown SA, Kouzekanani K, Hanis CL. The Starr County Diabetes Education Study: development of the Spanish-language diabetes knowledge questionnaire. Diabetes Care 2001;24(1):16-21. http://doi.org/d65pjf

  16. Prado-Aguilar CA, Martinez YV, Segovia-Bernal Y, Reyes-Martinez R, rias-Ulloa R. Performance of two questionnaires to measure treatment adherence in patients with Type-2 diabetes. BMC Public Health 2009;9:38. http://doi.org/dkt2cz

  17. Stanford Patient Education Research Center. Diabetes Self-Efficacy Scale. Stanford Patient Education Research Center 2009 [accessed on 2014 October 10]. Available at: http://patienteducation.stanford.edu/ research/sediabetes.html

  18. Vincent D, McEwen MM, Pasvogel A. The validity and reliability of a Spanish version of the summary of diabetes self-care activities questionnaire. Nurs Res 2008;57(2):101-106. http://doi.org/cg2xv6

  19. Mead N, Bower P, Roland M. The General Practice Assessment Questionnaire (GPAQ) - development and psychometric characteristics. BMC Fam Pract 2008;9:13. http://doi.org/dfsm2g

  20. Velazquez-Abad DE. Validez de criterio concurrente de un cuestionario que valora la comunicación en la relación medico-paciente en Diabetes Mellitu tipo 2 [dissertation]. Aguascalientes (Ags): Universidad Autonoma de Aguascalientes, 2010.

  21. Prado-Aguilar CA. Indicadores de la calidad de atencion del medico familiar asociados a la severidad de la retinopatia en diabeticos tipo 2 [thesis]. Guadalajara (Jal): Universidad de Guadalajara-University of Washington, 2007.

  22. Jurado S, Villegas ME, Mendez L, Rodriguez F, Loperena V, Varela R. La estandarizacion del Inventario de Depresion de Beck para los residentes de la ciudad de Mexico. Salud Ment (Mex) 1998;21(3):26-31.

  23. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009;41(4):1149-1160. http://doi.org/b22kn7

  24. Steiger JH. Tests for comparing elements of a correlation matrix. Psychol Bull 1980;87(2):245-251. http://doi.org/dkrqw7

  25. Aiken LS, West SG. Multiple regression: testing and interpreting interactions. California, USA, Sage Publications, 1991.

  26. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall, 1993. http://doi.org/bfdc

  27. The CONSORT Flow Diagram [internet]. Ottawa: The Ottawa Hospital Research Institute, 2010 [accessed on 2014 October 10]. Available at: http://www. consort-statement.org/consort-statement/flow-diagram

  28. Sidorenkov G, Haaijer-Ruskamp FM, Bilo H, Denig P. Review: relation between quality-of-care indicators for diabetes and patient outcomes: a systematic literature review. Med Care Res Rev 2011;68(3):263-289. http://doi.org/bft7gq

  29. Katon W, Russo J, Lin EH, Heckbert SR, Karter AJ, Williams LH, et al. Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosomatic Medicine 2009;71(9):965-972. http://doi.org/d7z437

  30. Brown JB, Nichols GA. Slow response to loss of glycemic control in type 2 diabetes mellitus. Am J Manag Care 2003;9(3):213-217.

  31. Riddle M, Umpierrez G, DiGenio A, Zhou R, Rosenstock J. Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes. Diabetes Care 2011;34(12):2508-2514. http://doi.org/cp2gt7

  32. Fu AZ, Qiu Y, Davies MJ, Radican L, Engel SS. Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy. Diabetes Obes Metab 2011;13(8):765-769. http://doi.org/c5z4m6

  33. Grant RW, Pabon-Nau L, Ross KM, Youatt EJ, Pandiscio JC, Park ER. Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines. Diabetes Educ 2011;37(1):78-84. http://doi.org/b5bzsw

  34. Fonseca VA. Defining and characterizing the progression of type 2 diabetes. Diabetes Care 2009;32 Suppl 2:S151-S156. http://doi.org/cwj9wr

  35. Marchetti P, Lupi R, Del GS, Bugliani M, D’Aleo V, Occhipinti M, et al. Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control. Diabetes Care 2009;32 Suppl 2:S178-S183. http://doi.org/c9fjz5

  36. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 1999;281(21):2005-2012. http://doi.org/ddp27p

  37. Deakin T, McShane CE, Cade JE, Williams RD. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005;(2):CD003417. http://doi.org/ckn4fz

  38. Gary TL, Genkinger JM, Guallar E, Peyrot M, Brancati FL. Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educ 2003;29(3):488-501. http://doi.org/bw2jkr

  39. Sarkisian CA, Brown AF, Norris KC, Wintz RL, Mangione CM. A systematic review of diabetes self-care interventions for older, African American, or Latino adults. Diabetes Educ 2003;29(3):467-479. http://doi.org/ch8z7x

  40. Jiménez-Corona A, Aguilar-Salinas CA, Rojas-Martínez R, HernándezÁvila M. Diabetes mellitus tipo 2 y frecuencia de acciones para su prevención y control. Salud Publica Mex 2013;55 supl 2:S137-S143.

  41. Altman DG. Statistics in medical journals: some recent trends. Stat Med 2000;19(23):3275-3289. http://doi.org/dh89jh

  42. Kristman V, Manno M, Cote P. Loss to follow-up in cohort studies: how much is too much? Eur J Epidemiol 2004;19(8):751-760. http://doi.org/frjpwj




2020     |     www.medigraphic.com